Jing-xing Yang
Miaoli, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
TLR9 and STING agonists adjuvanted varicella-zoster virus glycoprotein E induced a potent and durable nasal vaccine response.
Journal: Human vaccines & immunotherapeutics
Published: January 13, 2026
Cooperative tumor inhibition by CpG-oligodeoxynucleotide and cyclic dinucleotide in head and neck cancer involves T helper cytokine and macrophage phenotype reprogramming.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 23, 2024
Tumor promoting effect of PDLIM2 downregulation involves mitochondrial ROS, oncometabolite accumulations and HIF-1α activation.
Journal: Journal of experimental & clinical cancer research : CR
Published: January 24, 2024
Induction of Immune Responses and Phosphatidylserine Exposure by TLR9 Activation Results in a Cooperative Antitumor Effect with a Phosphatidylserine-targeting Prodrug.
Journal: International journal of biological sciences
Published: December 08, 2022
TLR9 and STING agonists cooperatively boost the immune response to SARS-CoV-2 RBD vaccine through an increased germinal center B cell response and reshaped T helper responses.
Journal: International journal of biological sciences
Published: November 24, 2022
Sharpening up tumor microenvironment to enhance the efficacy of immune checkpoint blockade on head and neck cancer using a CpG-oligodeoxynucleotide.
Journal: Cancer immunology, immunotherapy : CII
Published: March 23, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026